UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-26 | Future report Set alerts | |
| Q2 2022 | 2022-08-04 | 0.47 | 0.47 |
| Q1 2022 | 2022-04-28 | 0.33 | 0.33 |
| Q4 2021 | 2022-02-17 | 0.52 | 0.52 |
| Q3 2021 | 2021-10-28 | 0.46 | 0.46 |
| Q2 2021 | 2021-08-06 | 0.41 | 0.41 |
| Q1 2021 | 2021-05-07 | 0.24 | 0.24 |
| Q4 2020 | 2021-02-18 | 0.25 | 0.25 |
| Q3 2020 | 2020-10-20 | 0.00 | 0.00 |
| Q2 2020 | 2020-07-30 | 0.32 | 0.09 |
| 2016-06-08 | Reiterated Rating | Jefferies Group | Buy | $80.00 |
| 2016-05-16 | Reiterated Rating | Robert W. Baird | Buy | |
| 2016-04-29 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-04-29 | Boost Price Target | Mizuho | Buy | $75.00 to $79.00 |
| 2016-03-14 | Reiterated Rating | Piper Jaffray | Overweight | $76.00 |
| 2016-03-14 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $76.00 |
| 2016-03-08 | Lower Price Target | Stifel Nicolaus | Buy | $81.00 to $76.00 |
| 2016-03-07 | Downgrade | Susquehanna | Positive to Neutral | $94.00 to $70.00 |
| 2015-12-02 | Reiterated Rating | Stephens | Equal Weight | $77.00 |
| 2015-11-30 | Reiterated Rating | Jefferies Group | Buy | $98.00 to $88.00 |
| 2015-11-03 | Lower Price Target | Stifel Nicolaus | Buy | $91.00 to $81.00 |
| 2015-10-30 | Lower Price Target | Piper Jaffray | $90.00 to $85.00 | |
| 2015-10-30 | Lower Price Target | JPMorgan Chase & Co. | $94.00 to $85.00 | |
| 2015-10-02 | Initiated Coverage | Citigroup Inc. | Neutral | |
| 2015-09-30 | Initiated Coverage | Mizuho | Buy | $88.00 to $88.00 |
| 2015-09-20 | Reiterated Rating | William Blair | Buy | |
| 2015-09-16 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $94.00 |
| 2015-08-25 | Boost Price Target | Stifel Nicolaus | Buy | $90.00 to $91.00 |
| 2015-07-31 | Boost Price Target | Dougherty & Co | Buy | $88.00 to $90.00 |
| 2015-05-23 | Reiterated Rating | Deutsche Bank | Buy | $77.00 to $79.00 |
| 2015-05-23 | Reiterated Rating | Deutsche Bank AG | Buy | $77.00 to $79.00 |
| 2015-05-22 | Boost Price Target | Dougherty & Co | Buy | $80.00 to $88.00 |
| 2015-05-13 | Boost Price Target | Raymond James | Outperform | $78.00 to $80.00 |
| 2015-05-13 | Boost Price Target | Raymond James Financial Inc. | Outperform | $78.00 to $80.00 |
| 2015-02-06 | Upgrade | Stifel Nicolaus | Hold to Buy | $77.00 |
| 2015-01-30 | Boost Price Target | Citigroup Inc. | Buy | $72.00 to $80.00 |
| 2015-01-30 | Boost Price Target | Deutsche Bank | Buy | $75.00 to $76.00 |
| 2015-01-30 | Boost Price Target | Jefferies Group | Buy | $69.00 to $80.00 |
| 2014-10-31 | Reiterated Rating | Citigroup Inc. | Buy | $65.00 to $72.00 |
| 2014-10-08 | Initiated Coverage | Robert W. Baird | Outperform | $62.00 |
| 2014-09-16 | Initiated Coverage | SunTrust | Neutral | $62.00 |
| 2014-09-16 | Initiated Coverage | SunTrust Banks Inc. | Neutral | $62.00 |
| 2014-09-15 | Reiterated Rating | Deutsche Bank | Buy | $73.00 to $76.00 |
| 2014-07-08 | Initiated Coverage | Susquehanna | Positive | |
| 2014-05-05 | Reiterated | Dougherty & Company | Buy | $63 to $66 |
| 2014-05-05 | Boost Price Target | Dougherty & Co | Buy | $63.00 to $66.00 |
| 2014-04-17 | Reiterated Rating | Jefferies Group | Buy | $69.00 |
| 2014-04-01 | Upgrade | Deutsche Bank | Hold to Buy | $57.00 to $73.00 |
| 2013-12-17 | Initiated Coverage | KeyBanc | Hold | |
| 2013-11-04 | Reiterated | Dougherty & Company | Buy | $110 to $125 |
| 2013-11-04 | Boost Price Target | Dougherty & Co | Buy | $110.00 to $125.00 |
| 2013-11-01 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2013-10-31 | Reiterated Rating | Deutsche Bank | In-Line | $104.00 to $109.00 |
| 2013-10-09 | Boost Price Target | Deutsche Bank | Hold | $91.00 to $104.00 |
| 2013-02-01 | Reiterated | Dougherty & Company | Buy | $95 to $110 |
| 2012-12-21 | Reiterated | Feltl & Co. | Buy | $86 to $91 |
| 2012-08-01 | Reiterated | Dougherty & Company | Buy | $80 to $95 |
| 2012-07-18 | Downgrade | Deutsche Bank | Hold to Sell | $73 to $58 |
| 2012-05-04 | Downgrade | Deutsche Bank | Buy to Hold | $81 to $73 |
| 2012-02-06 | Reiterated | Dougherty & Company | Buy | $90 to $100 |
| 2011-12-22 | Initiated | BB&T Capital Mkts | Buy | $80 |
| 2011-07-27 | Upgrade | Morgan Keegan | Mkt Perform to Outperform | $70 to $85 |
| 2011-02-04 | Reiterated | Kaufman Bros | Buy | $83 to $80 |
| 2011-01-04 | Reiterated | Kaufman Bros | Buy | $69 to $83 |
| 2010-12-20 | Upgrade | RBC Capital Mkts | Sector Perform to Top Pick | $68 to $79 |
| 2016-06-08 | Reiterated Rating | Jefferies Group | Buy | $80.00 |
| 2016-05-16 | Reiterated Rating | Robert W. Baird | Buy | |
| 2016-04-29 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-04-29 | Boost Price Target | Mizuho | Buy | $75.00 to $79.00 |
| 2016-03-14 | Reiterated Rating | Piper Jaffray | Overweight | $76.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In MD 199 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 13.57M |
| Vanguard Group, Inc | 9.67M |
| EARNEST PARTNERS LLC | 6.76M |
| ALLIANCEBERNSTEIN L.P. | 6.50M |
| LAZARD ASSET MANAGEMENT LLC | 6.02M |
| Starboard Value LP | 5.92M |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 4.05M |
| BlackRock Fund Advisors | 3.80M |
| Arrowpoint Asset Management, LLC | 3.64M |
| DIMENSIONAL FUND ADVISORS LP | 3.40M |
| STATE STREET CORP | 3.37M |
| River Road Asset Management, LLC | 2.90M |
| BlackRock Institutional Trust Company, N.A. | 2.90M |
| NEW YORK STATE COMMON RETIREMENT FUND | 1.53M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.47M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| MEDEL ROGER MD Chief Executive Officer | 1.43% (1436178) | MD / |
| CALABRO JOSEPH M Chief Operating Officer | 0.35% (354933) | MD / |
| Kadre Manuel | 0.12% (115897) | MD / RSG / |
| Lopez-Blanco Vivian Chief Financial Officer | 0.11% (107985) | MD / |
| WAGNER KARL B Pres, American Anesthesiology | 0.11% (105932) | MD / |
| FERNANDEZ MICHAEL | 0.10% (96589) | MD / |
| Clark David A. COO / Pediatrix Division | 0.04% (44452) | MD / |
| HAWKINS THOMAS W SVP, General Counsel and Secy. | 0.04% (43297) | MD / |
| Andreano Dominic J SVP, General Counsel and Secy | 0.04% (41039) | MD / |
| Pepia John C Principal Accounting Officer | 0.04% (36716) | MD / |
| ALVAREZ CESAR L | 0.04% (35897) | JOE / MD / WSO / XON / |
| Stanley Michael D President, Pediatrix Division | 0.04% (35247) | MD / |
| SOSA ENRIQUE | 0.02% (21306) | MD / |
| Goldschmidt, MD Pascal J | 0.02% (20422) | HMA / MD / |
| SHALALA DONNA E | 0.02% (16947) | LEN / MD / |
| WALDEMAR, MD CARLO A | 0.02% (15897) | MD / |
| GABOS PAUL G | 0.02% (15897) | HIIQ / MD / |
| Hawk William C COO American Anesthesiology | 0.01% (11549) | MD / |
| Barker Karey D | 0.01% (9362) | MD / |
| FREEMAN ROGER K | 0.01% (7013) | MD / |
UM